Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Caliburn Partnership was a leading independent Australian corporate advisory firm and investment bank specializing in mergers and acquisitions, capital markets, and strategic financial advice. Founded in 1999 by Peter Hunt and Simon Mordant, the firm became one of the most successful independent advisors in the Asia-Pacific region, frequently advising on high-profile transactions in the healthcare and pharmaceutical sectors, such as the acquisition of Sigma Pharmaceuticals' generics business. In 2010, the firm was acquired by the global investment bank Greenhill & Co., subsequently operating as Greenhill Caliburn before fully integrating into the Greenhill brand. While not a life sciences company itself, it played a significant role in the consolidation and financing of the Australian healthcare industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Caliburn Partnership.